Internal Medicine · Vineland, NJ
NPI
1366477697
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1505 W Sherman Ave, Suite 101
Vineland, NJ, 08360
Phone (856) 696-9550
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
181,935 services
Medicare patients, 2024
632
Average age 75
Drug cost, 2024
$6.7M
2,763 prescriptions
Company payments, 2025
$3,304
From 55 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Benjamin P Negin was code J1439 (injection, ferric carboxymaltose, 1 mg), 54,000 times for 46 patients. In total Benjamin P Negin billed 181,935 services in 113 codes, and Medicare paid $2.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 54,000 | 46 | $0.84 | $45K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,200 | 15 | $44.55 | $410K |
| J9267 Injection, paclitaxel, 1 mg | Office | 9,134 | 13 | $0.08 | $724 |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 7,656 | 26 | $21.47 | $164K |
| J0897 Injection, denosumab, 1 mg | Office | 6,120 | 20 | $20.67 | $127K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 4,800 | 14 | $0.11 | $517 |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2,520 | 18 | $5.75 | $14K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 1,880 | 20 | $6.22 | $12K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,676 | 62 | $0.09 | $150 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,408 | 24 | $0.07 | $103 |
| 85025 Blood Count | Office | 1,111 | 340 | $7.51 | $8,347 |
| 99213 Office E&M - Established | Office | 914 | 390 | $75.82 | $69K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 690 | 35 | $0.71 | $488 |
| 96375 Injection Administration | Office | 408 | 71 | $13.76 | $5,616 |
| 96372 Injection Administration | Office | 292 | 105 | $12.30 | $3,592 |
By year: 2022 $2.4M for 151,872 services; 2023 $2.3M for 154,396 services; 2024 $2.1M for 181,935 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,111 | 340 | $7.51 | $8,347 |
| 80053 Clinical Chemistry | 70 | 34 | $10.35 | $725 |
Medicare prescription drug claims, 2024
In 2024, the drug Benjamin P Negin prescribed most often to Medicare patients was Eliquis (Apixaban), with 207 prescriptions and refills. In total Benjamin P Negin wrote 2,763 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 207 | 357 | 61 | $201K |
| Oxycodone Hcl Generic | 179 | 179 | 53 | $3,084 |
| Letrozole Generic | 148 | 365 | 46 | $4,514 |
| Prednisone Generic | 83 | 96 | 39 | $366 |
| Xarelto Rivaroxaban | 82 | 154 | 23 | $83K |
| Keytruda Pembrolizumab | 71 | 71 | Under 11 | $789K |
| Dexamethasone Sodium Phosphate Generic | 62 | 62 | 18 | $123 |
| Gabapentin Generic | 62 | 66 | 18 | $498 |
| Ondansetron Odt Ondansetron | 57 | 57 | 27 | $987 |
| Palonosetron Hcl Generic | 50 | 50 | 18 | $2,510 |
| Hydroxyurea Generic | 48 | 107 | 18 | $1,627 |
| Carboplatin Generic | 44 | 44 | 12 | $3,734 |
| Tamoxifen Citrate Generic | 43 | 100 | 13 | $1,239 |
| Neulasta Pegfilgrastim | 42 | 44 | 13 | $312K |
| Lactulose Generic | 39 | 40 | 19 | $329 |
Brand drugs: 924 claims; generic drugs: 1,839 claims; opioid claims: 302.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Benjamin P Negin $3,304 ($3,304 in general payments such as food, travel and fees) from 55 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $306.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $306 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $293 |
| GlaxoSmithKline, LLC. GSK | 13 | $221 |
| Daiichi Sankyo Inc. 4568.T | 11 | $202 |
| Pfizer Inc. PFE | 11 | $154 |
| Abbvie Inc. ABBV | 10 | $135 |
| Astellas Pharma US Inc 4503.T | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $98.88 |
| Merck Sharp & Dohme LLC MRK | 5 | $95.67 |
| Sobi, Inc SOBI.ST | 5 | $83.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.